Skip to main content
. Author manuscript; available in PMC: 2020 Dec 22.
Published in final edited form as: Expert Opin Orphan Drugs. 2019 Nov 27;7(11):473–500. doi: 10.1080/21678707.2019.1684258

Table II.

Human Clinical Trials for Neuronal Ceroid Lipofuscinoses (Observational clinical studies)1

NCL/Study Title Treatment Phase Number Enrolled Status NCT Number2
All CLN types
 Clinical and Neuropsychological Investigations in Batten Disease Natural history only, no treatment none (observational) 400 Recruiting NCT01873924
 Neuronal Ceroid Lipofuscinosis and Associated Sleep Abnormalities Natural history only, no treatment none (observational) 57 Completed NCT01966757
 Genetic Characterization of Movement Disorders and Dementias Natural history only, no treatment none (observational) 12,000 Recruiting NCT02014246
 Inherited Retinal Degenerative Disease Registry Natural history only, no treatment none (observational) 20,000 Recruiting NCT02435940
 Longitudinal Study of Neurodegenerative Disorders Hematopoietic Stem Cell Transplantation none (observational) 1,500 Recruiting NCT03333200
CLN2
 Genotype - Phenotype Correlations of LINCL Natural history only, no treatment none (observational) 18 Completed NCT00151268
 Genotype-Phenotype Correlations of Late Infantile Neuronal Ceroid Lipofuscinosis Natural history only, no treatment none (observational) 75 Active, not recruiting NCT01035424
 Collection of Cerebrospinal Fluid in Healthy Children none (normal controls) none (observational) 32 Terminated NCT01698229
CLN3
 Investigations of Juvenile Neuronal Ceroid Lipofuscinosis Natural history only, no treatment none (observational) 50 Recruiting NCT03307304
CLN6
 Natural History of Neuronal Ceroid Lipofuscinosis, Batten’s CLN6 Disease Natural history only, no treatment none (observational) 15 Recruiting NCT03285425
1

Abbreviations: neuronal ceroid lipofuscinosis (NCL); late infantile neuronal ceroid lipofuscinosis (LINCL)

2

Clinical identifier numbers obtained from clinicaltrials.gov website